Target intelligence / Profile preview

Cancer cell plasma membrane lipid raft microdomain (LR)

Target
LR
Molecular classification
Membrane microdomain, Lipid bilayer component, Other
01

Overview

Lipid rafts are specialized, highly ordered microdomains within the plasma membrane lipid bilayer, enriched in cholesterol, sphingolipids, and specific proteins like caveolins and flotillins (Mollinedo & Gajate, 2015). In cancer cells, these microdomains are often more abundant or altered in composition, serving as critical platforms for the assembly and activation of pro-survival and pro-migratory signaling pathways, including the PI3K/Akt and MAPK pathways (Patra, 2008). Targeting these structures, a strategy known as membrane lipid therapy, aims to disrupt the spatial organization of oncogenic receptors and signaling molecules (Li et al., 2022). Drugs such as synthetic alkylphospholipids, including edelfosine and miltefosine, selectively accumulate in cancer cell rafts, inducing apoptosis by displacing survival signals or recruiting death receptors like Fas/CD95 (Gajate & Mollinedo, 2014). While promising for overcoming multidrug resistance, the therapeutic challenge lies in achieving high selectivity for malignant rafts over those in healthy cells to minimize systemic toxicity (Greenlee et al., 2021).

Other names
Lipid raftsDetergent-resistant membranesMembrane microdomainsCholesterol-rich microdomainsLiquid-ordered domains
02

Mechanism of action

Disruption of membrane microdomain structural integrity, depletion of membrane cholesterol, and displacement of oncogenic signaling proteins from the plasma membrane to induce apoptosis.

03

Biological functions

Signal transductionProtein traffickingEndocytosisCell adhesionApoptosis regulation
04

Disease associations

CancerMetastasisDrug resistance
05

Safety considerations

Off-target effects on healthy cell membranesHemolysisGastrointestinal toxicityImpairment of normal physiological signaling
06

Interacting drugs

Edelfosine

7 more in the full profile.

07

Biomarkers

Caveolin-1Flotillin-1Membrane cholesterol levelsGM1 ganglioside

Beyond the preview

Go deeper on Cancer cell plasma membrane lipid raft microdomain (LR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer cell plasma membrane lipid raft microdomain (LR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call